by TractManager | Nov 23, 2022 | Emerging Technology Report
The Flowsense device is a wireless, noninvasive thermal flow sensor in development for the detection of flow in implanted cerebrospinal fluid shunts in patients with hydrocephalus.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Nov 22, 2022 | Health Technology Assessment
Focus of the Report: This Health Technology Assessment (HTA) focuses on high-intensity focused ultrasound (HIFU) for primary treatment of localized prostate cancer (PCa).Technology Description: HIFU is a minimally invasive treatment that ablates malignant prostatic...
by TractManager | Nov 21, 2022 | Emerging Technology Report
Teplizumab is an intravenously administered anti-CD3 monoclonal antibody indicated to delay the onset of stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with stage 2 T1D. If you have a Hayes login, click here to view the full...
by TractManager | Nov 17, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Evoke SCS System for pain reduction and decreased opioid use related to chronic intractable back and leg...
by TractManager | Nov 8, 2022 | Emerging Technology Report
Bulevirtide is an investigational, first-in-class subcutaneously injected virion entry inhibitor proposed for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease. If you have a Hayes login, click here to view the...
Recent Comments